Furthermore, lectins have the potential to inhibit the virion infection of HIV-1 toward the host CD4+ T-lymphocyte cells by interacting with HIV envelope glycoproteins gp120 and gp41 and binding the CD4+, CXCR4, or CCR5 receptors [129,130]. This evidence concerns the gene CD4 and infection.